GO:0001678 intracellular glucose homeostasis: Cellular Energy Balance, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001678 intracellular glucose homeostasis is the biological process that maintains a steady-state level of glucose inside a cell, as defined by QuickGO.
• It integrates glucose uptake, glycolysis, gluconeogenesis, glycogen turnover, mitochondrial oxidation, and organelle crosstalk.
• Mitochondria are central hubs: fatty acid beta-oxidation, mitophagy, and mitochondrial transfer all influence cellular glucose balance.
• Key regulators include YAP/TAZ, TRAF6, Parkin, TAK1, MCT1, TGM2, and FGF13, which link metabolism to immunity, ER-mitochondria contacts, and systemic energy status.
• Dysregulated intracellular glucose homeostasis contributes to beta-cell dysfunction, neuronal amyloidogenesis, metabolic syndrome, and inflammatory disease.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of these genes in cellular glucose handling.
Description
Intracellular glucose homeostasis (GO:0001678) is the homeostatic process that maintains a steady-state level of glucose within a cell. Unlike systemic glucose homeostasis, which is measured in blood, this term focuses on the concentration and flux of glucose inside cellular compartments, where it fuels glycolysis, the pentose phosphate pathway, and mitochondrial oxidation. Because glucose is both a metabolic substrate and a signaling molecule, its intracellular level must be tightly controlled to match energy demand, biosynthetic needs, and stress conditions. Researchers study this process to understand how cells adapt to nutrient availability, how metabolic dysfunction arises in disease, and how organelles such as mitochondria and the endoplasmic reticulum communicate to buffer glucose fluctuations. The QuickGO definition emphasizes a homeostatic process involved in the maintenance of a steady state level of glucose within a cell, and synonyms include cell glucose homeostasis and cellular glucose homeostasis. This article synthesizes published evidence on the mechanisms, genes, and experimental models used to investigate GO:0001678, with a focus on mitochondrial and signaling pathways that converge on cellular glucose balance.
intracellular glucose homeostasis At A Glance
| GO ID | GO:0001678 |
|---|---|
| GO term | intracellular glucose homeostasis |
| Ontology | biological_process |
| Synonym | cell glucose homeostasis; cellular glucose homeostasis |
| Definition | A homeostatic process involved in the maintenance of a steady state level of glucose within a cell. |
| Major function | Maintains intracellular glucose levels for energy production, biosynthesis, and signaling. |
| Key organelles | Cytosol, mitochondria, endoplasmic reticulum, and plasma membrane transport systems. |
| Representative regulators | YAP/TAZ, TRAF6, Parkin, TAK1, MCT1, TGM2, FGF13. |
| Disease relevance | Beta-cell dysfunction, neuronal amyloidogenesis, metabolic syndrome, inflammatory and mitophagy-related disorders. |
What Is GO:0001678?
In plain terms, GO:0001678 describes how a cell keeps its internal glucose level stable despite changes in nutrient supply and energy demand. The QuickGO definition states that it is a homeostatic process involved in the maintenance of a steady state level of glucose within a cell. This includes balancing glucose entry, storage as glycogen, breakdown through glycolysis, and mitochondrial oxidation, as well as recycling pathways that regenerate glucose. The process is not a single reaction but a network of transport, enzymatic, and signaling events that operate across the cytosol, mitochondria, and other organelles.
Why Is intracellular glucose homeostasis Important in Cell Biology?
Intracellular glucose homeostasis is important because glucose is the primary fuel for many cell types and a key substrate for biosynthetic pathways, yet excess or insufficient intracellular glucose can trigger oxidative stress, protein misfolding, and cell death. Defects in this process are linked to impaired insulin secretion, neuronal dysfunction, and systemic metabolic disease. Understanding GO:0001678 therefore provides a mechanistic bridge between organelle biology, signaling networks, and human disease, and it guides the development of targeted experimental models.
• Maintains energy supply for ATP production and biosynthetic reactions.
• Supports insulin secretion and beta-cell function through glucose sensing.
• Links mitochondrial metabolism, including fatty acid beta-oxidation, to cellular glucose balance.
• Integrates innate immune signaling with metabolic control via TRAF6 and Parkin.
• Regulates ER-mitochondria calcium crosstalk and neuronal amyloidogenesis under high glucose.
• Influences systemic metabolic health through ceramide-induced FGF13.
• Coordinates astrocyte-to-neuron mitochondrial transfer for glucose and cholesterol homeostasis.
• Provides a mechanistic basis for understanding metabolic syndrome and neurodegeneration.
• Guides CRISPR-based functional studies of metabolic genes.
• Helps identify therapeutic targets for diseases of glucose dysregulation.
What Happens During intracellular glucose homeostasis?
Glucose uptake and phosphorylation
In simple terms: The cell first brings glucose inside and traps it by adding a phosphate group.
Glucose enters the cell through transporters and is rapidly phosphorylated to glucose-6-phosphate, which prevents efflux and commits the sugar to metabolism. This step is sensitive to energy status and is coupled to signaling pathways that sense nutrient availability. Mitochondrial function and oxidative metabolism influence the capacity for continued glucose uptake and utilization.
Glycolysis and mitochondrial oxidation
In simple terms: Glucose is broken down to pyruvate, which mitochondria use to make energy.
Glycolysis converts glucose-6-phosphate to pyruvate, generating ATP and NADH, while mitochondria oxidize pyruvate and fatty acids to sustain energy production. Mitochondrial fatty acid beta-oxidation provides acetyl-CoA that feeds the TCA cycle, and its activity is integrated with glucose handling. Mitochondrial quality control, including mitophagy, helps maintain the metabolic capacity needed for glucose homeostasis.
Organelle crosstalk and calcium signaling
In simple terms: Different organelles talk to each other to keep glucose and calcium levels balanced.
ER-mitochondria contacts regulate calcium transfer and influence glucose-induced stress responses, as shown by TGM2-dependent modulation of ER-mitochondria contacts under high glucose. Mitochondrial transfer from astrocytes to POMC neurons supports glucose and cholesterol homeostasis, illustrating intercellular organelle communication. These contact sites help coordinate metabolic flux with stress and survival signaling.
Signaling integration by YAP/TAZ and immune-metabolic regulators
In simple terms: Growth and immune signals adjust how the cell uses glucose.
YAP/TAZ signaling intersects with metabolism to influence glucose utilization and cellular energy balance. TRAF6 integrates innate immune signals to regulate glucose homeostasis through Parkin-dependent and Parkin-independent mitophagy. TAK1 licenses mitochondrial transfer from astrocytes to POMC neurons, linking stress kinases to metabolic control.
Lactate shuttle and beta-cell modulation
In simple terms: Lactate produced by one cell can be shuttled to mitochondria and affect glucose control in another cell.
MCT1-mediated lactate shuttle to mitochondria governs macrophage polarization and modulates glucose homeostasis by affecting beta cells. This demonstrates that intracellular glucose homeostasis in one cell type can be influenced by metabolic intermediates exchanged with other cells. Such intercellular coupling is relevant to inflammation and pancreatic islet function.
Key Genes Involved in GO:0001678 intracellular glucose homeostasis
The following genes and proteins have been experimentally linked to intracellular glucose homeostasis or its regulatory network in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MCT1 (SLC16A1) | Mediates lactate shuttle to mitochondria in macrophages | Links macrophage polarization to beta-cell glucose homeostasis |
| YAP1 | Transcriptional co-activator in Hippo signaling | Connects growth signaling to metabolic regulation |
| WWTR1 (TAZ) | Transcriptional co-activator in Hippo signaling | Interplay with metabolism and glucose utilization |
| TRAF6 | E3 ubiquitin ligase in innate immune signaling | Regulates glucose homeostasis via Parkin-dependent and independent mitophagy |
| PRKN (Parkin) | E3 ubiquitin ligase in mitophagy | Mediates TRAF6 effects on glucose homeostasis |
| MAP3K7 (TAK1) | Stress-activated kinase | Licenses mitochondrial transfer to POMC neurons for glucose homeostasis |
| TGM2 | Transglutaminase 2 | Modulates ER-mitochondria contacts and calcium homeostasis under high glucose |
| FGF13 | Fibroblast growth factor family member | Ceramide-induced FGF13 impairs systemic metabolic health |
| CPT1A | Rate-limiting enzyme in mitochondrial fatty acid oxidation | Fatty acid beta-oxidation influences glucose metabolism |
| ACADM | Medium-chain acyl-CoA dehydrogenase | Genetic disorders of beta-oxidation affect energy homeostasis |
| HADHA | Mitochondrial trifunctional protein subunit | Beta-oxidation defects impact metabolic balance |
| PPARGC1A (PGC-1alpha) | Mitochondrial biogenesis regulator | Mitochondrial function supports glucose homeostasis |
| INS | Insulin | Beta-cell glucose sensing and insulin secretion |
| SLC2A2 (GLUT2) | Facilitative glucose transporter | Glucose uptake in beta cells and liver |
| GCK | Glucokinase | Glucose phosphorylation and sensing |
| POMC | Pro-opiomelanocortin neuron marker | Receives mitochondrial transfer for glucose homeostasis |
| MFN2 | Mitochondrial fusion protein | Mitochondrial dynamics influence metabolic homeostasis |
How Is intracellular glucose homeostasis Regulated?
Intracellular glucose homeostasis is regulated by a network of signaling pathways and organelle quality-control systems. YAP/TAZ signaling integrates growth cues with metabolic gene expression. TRAF6 and Parkin control mitophagy, which removes damaged mitochondria and sustains metabolic capacity for glucose handling. TAK1 regulates mitochondrial transfer from astrocytes to POMC neurons, coupling stress signaling to metabolic homeostasis. MCT1-mediated lactate shuttling modulates beta-cell function and macrophage polarization, providing an intercellular layer of regulation. TGM2-dependent ER-mitochondria contacts and calcium signaling respond to high glucose and influence neuronal amyloidogenesis. Ceramide-induced FGF13 impairs systemic metabolic health, indicating lipid-derived signals can disrupt glucose balance. Mitochondrial fatty acid beta-oxidation and its genetic disorders further illustrate how mitochondrial flux regulates glucose metabolism.
intracellular glucose homeostasis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MCT1 (SLC16A1) | Beta-cell dysfunction and inflammation | Macrophage-specific knockout and co-culture with beta cells |
| TGM2 | Neuronal amyloidogenesis under high glucose | Neuronal cell line with TGM2 knockout or point mutation |
| TRAF6 | Immune-metabolic dysregulation and mitophagy defects | TRAF6 knockout with Parkin rescue |
| FGF13 | Ceramide-induced metabolic syndrome | Adipocyte or hepatocyte overexpression |
| TAK1 (MAP3K7) | Neuronal glucose and cholesterol imbalance | POMC neuron-specific knockout |
Metabolic and beta-cell dysfunction
Disrupted intracellular glucose homeostasis contributes to beta-cell dysfunction and impaired insulin secretion. MCT1-mediated lactate shuttle in macrophages modulates glucose homeostasis by affecting beta cells, linking inflammation to islet dysfunction. Ceramide-induced FGF13 impairs systemic metabolic health, providing a mechanism for lipid-induced metabolic disease. Mitochondrial fatty acid beta-oxidation disorders also disturb energy homeostasis and can present with metabolic decompensation.
Neurodegeneration and neuronal stress
High glucose conditions promote neuronal amyloidogenesis through TGM2-dependent ER-mitochondria contacts and calcium homeostasis, connecting glucose dysregulation to Alzheimer's disease-like pathology. TAK1-dependent mitochondrial transfer from astrocytes to POMC neurons is required for glucose and cholesterol homeostasis, and its disruption may affect neuronal function. These findings suggest that intracellular glucose homeostasis is important for neuronal survival and proteostasis.
Inflammation and immune-metabolic disease
TRAF6 integrates innate immune signals to regulate glucose homeostasis via Parkin-dependent and Parkin-independent mitophagy, linking immune activation to metabolic control. MCT1-mediated lactate shuttle governs macrophage polarization, which in turn affects beta-cell glucose homeostasis. YAP/TAZ signaling also intersects with metabolism, and its dysregulation may contribute to immune-metabolic disorders.
From intracellular glucose homeostasis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene alter intracellular glucose levels? | CRISPR knockout cell line with glucose uptake and lactate assays |
| Does a specific point mutation affect protein function in glucose homeostasis? | CRISPR point-mutation knock-in with metabolic phenotyping |
| Can a disease-associated variant be corrected? | CRISPR knock-in of wild-type allele with functional rescue |
| Where does the protein localize during glucose flux? | Endogenous tagged knock-in with live-cell imaging |
| Does overexpression mimic a metabolic disease state? | Doxycycline-inducible overexpression in relevant cell type |
| Which genes are essential for glucose homeostasis? | Genome-wide CRISPR library screening with glucose-dependent selection |
How to Study the intracellular glucose homeostasis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Glucose uptake assay | Rate of glucose entry into cells | Assess transporter function and insulin sensitivity |
| Seahorse extracellular flux | Oxygen consumption and extracellular acidification | Measure mitochondrial oxidation and glycolysis |
| Lactate assay | Lactate production or shuttle | Evaluate MCT1-dependent metabolic coupling |
| Live-cell calcium imaging | ER-mitochondria calcium transfer | Study TGM2-dependent contacts under high glucose |
| Mitochondrial transfer tracking | Intercellular mitochondrial movement | Investigate TAK1-dependent transfer to POMC neurons |
| RNA-seq | Transcriptome changes | Identify metabolic gene networks |
| CRISPR knockout screen | Gene essentiality under glucose stress | Discover novel regulators of glucose homeostasis |
| Mitophagy flux assay | Autophagic clearance of mitochondria | Assess Parkin-dependent and independent mitophagy |
Metabolic flux assays
Measuring glucose uptake, lactate production, and oxygen consumption provides direct readouts of intracellular glucose homeostasis. These assays can be combined with mitochondrial stress tests to assess oxidative capacity. Fatty acid beta-oxidation flux assays are useful when mitochondrial metabolism is implicated.
Genetically encoded sensors and imaging
Fluorescent glucose sensors and calcium indicators allow real-time monitoring of intracellular glucose and organelle crosstalk. ER-mitochondria contact sites can be visualized with split-fluorescent protein systems. Mitochondrial transfer between cells can be tracked using labeled mitochondria.
Transcriptomics and proteomics
RNA-seq and proteomics reveal global changes in metabolic gene expression upon perturbation of candidate regulators. Pathway enrichment can identify glucose homeostasis networks. Phosphoproteomics can uncover signaling nodes such as TAK1 and TRAF6.
CRISPR screening and functional genomics
Pooled CRISPR knockout screens under glucose-limited or high-glucose conditions identify genes required for intracellular glucose homeostasis. Follow-up validation with single-gene knockouts and rescue experiments establishes causality. Library screening can also uncover synthetic lethal interactions with metabolic inhibitors.
How CRISPR Can Be Used to Study GO:0001678 intracellular glucose homeostasis
Knockout
CRISPR knockout of candidate genes such as TRAF6, Parkin, or TGM2 allows researchers to test whether loss of function disrupts intracellular glucose homeostasis. Knockout cells can be challenged with high or low glucose and analyzed for viability, glucose uptake, and mitochondrial function. Rescue experiments with wild-type or mutant cDNA confirm specificity.
Point Mutation
Point-mutation knock-in models are used to study disease-associated variants or phospho-null/phospho-mimetic mutations in genes like TGM2 or TAK1. These models reveal how single amino acid changes affect ER-mitochondria contacts, calcium signaling, or mitochondrial transfer. They are also valuable for testing drug sensitivity.
Knock-in
Knock-in of reporter tags or disease alleles enables tracking of endogenous proteins during glucose flux. Tagged knock-in of mitochondrial or metabolic proteins allows live-cell imaging of organelle dynamics. Knock-in of patient variants can model metabolic disease in isogenic cell lines.
Overexpression
Overexpression of genes such as FGF13 or MCT1 can mimic gain-of-function states associated with metabolic dysfunction. Inducible overexpression systems allow temporal control to avoid adaptation. Overexpression combined with metabolic assays helps establish sufficiency in glucose homeostasis.
How EDITGENE Supports intracellular glucose homeostasis Research
Researchers studying intracellular glucose homeostasis-related genes often need to determine whether a candidate gene is causally involved in maintaining cellular glucose balance. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations, from knockout to knock-in, to support mechanistic and translational studies.
Contact EDITGENE today to design your custom CRISPR model for intracellular glucose homeostasis research.
Frequently Asked Questions About intracellular glucose homeostasis
What is intracellular glucose homeostasis?
Intracellular glucose homeostasis (GO:0001678) is the biological process that maintains a steady-state level of glucose within a cell, balancing uptake, storage, and oxidation.
What genes are involved in intracellular glucose homeostasis?
Key genes include MCT1, YAP1, WWTR1, TRAF6, PRKN, MAP3K7, TGM2, FGF13, and mitochondrial beta-oxidation genes such as CPT1A and ACADM.
How is intracellular glucose homeostasis regulated?
It is regulated by signaling pathways such as YAP/TAZ, TRAF6-Parkin mitophagy, TAK1-dependent mitochondrial transfer, and ER-mitochondria calcium crosstalk.
Why is intracellular glucose homeostasis important in disease?
Dysregulation contributes to beta-cell dysfunction, neuronal amyloidogenesis, metabolic syndrome, and inflammatory disorders.
What experimental models are used to study intracellular glucose homeostasis?
CRISPR knockout, point-mutation knock-in, tagged knock-in, overexpression cell lines, and pooled CRISPR screens are commonly used.
How does mitochondrial function relate to intracellular glucose homeostasis?
Mitochondria oxidize pyruvate and fatty acids, and mitochondrial quality control via mitophagy sustains the metabolic capacity needed for glucose homeostasis.
What is the role of MCT1 in glucose homeostasis?
MCT1 mediates a lactate shuttle to mitochondria in macrophages, which modulates glucose homeostasis by affecting beta cells.
Can CRISPR screens identify new regulators of intracellular glucose homeostasis?
Yes, pooled CRISPR knockout screens under glucose-defined conditions can discover novel genes required for maintaining cellular glucose balance.
What is the difference between intracellular and systemic glucose homeostasis?
Intracellular glucose homeostasis refers to glucose levels within a cell, while systemic glucose homeostasis refers to blood glucose regulation across the organism.
Which organelles are involved in intracellular glucose homeostasis?
The cytosol, mitochondria, endoplasmic reticulum, and plasma membrane transporters are all involved.
Conclusion
Intracellular glucose homeostasis (GO:0001678) is a central biological process that integrates glucose transport, glycolysis, mitochondrial oxidation, organelle crosstalk, and signaling networks to maintain cellular energy balance. Its dysregulation is implicated in beta-cell dysfunction, neurodegeneration, and metabolic disease, making it a high-priority area for mechanistic research. CRISPR-based cell models, combined with metabolic and imaging assays, provide powerful tools to dissect the causal roles of individual genes in this process. Continued investigation of GO:0001678 will likely reveal new therapeutic targets for metabolic and inflammatory disorders.
References
- 1. Chen L et al.. 2025. MCT1-mediated Lactate Shuttle to Mitochondria Governs Macrophage Polarization and Modulates Glucose Homeostasis by Affecting β Cells.. Adv Sci (Weinh) 12(38):e14760 PMID: 40660708
- 2. Koo JH et al.. 2018. Interplay between YAP/TAZ and Metabolism.. Cell Metab 28(2):196-206 PMID: 30089241
- 3. Houten SM et al.. 2016. The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders.. Annu Rev Physiol 78:23-44 PMID: 26474213
- 4. Lee HJ et al.. 2021. Urolithin A suppresses high glucose-induced neuronal amyloidogenesis by modulating TGM2-dependent ER-mitochondria contacts and calcium homeostasis.. Cell Death Differ 28(1):184-202 PMID: 32704090
- 5. Levi-D'Ancona E et al.. 2025. TRAF6 integrates innate immune signals to regulate glucose homeostasis via Parkin-dependent and Parkin-independent mitophagy.. Sci Adv 11(41):eadw4153 PMID: 41061082
- 6. Naderi J et al.. 2025. Ceramide-induced FGF13 impairs systemic metabolic health.. Cell Metab 37(5):1206-1222.e8 PMID: 40169001
- 7. Chandel NS. 2021. Mitochondria.. Cold Spring Harb Perspect Biol 13(3) PMID: 33649187
- 8. Yin K et al.. 2024. Tak1 licenses mitochondrial transfer from astrocytes to POMC neurons to maintain glucose and cholesterol homeostasis.. Cell Rep 43(12):114983 PMID: 39565693
